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The use of Intra Aortic Baloon Pump in Patients undergoing
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Hospital, Karachi
Aamir M. Jafarey,Muneer Amanullah,Sajid A. Khan,Sulaiman B. Hasan ( Department of Surgery, Aga Khan University
Hospital, Karachi. ) 
Abstract 
Objective: To review the experience in the use of Intra Aortic Balloon Pump (IABP) in patietits
undergoing Coronary Artery Bypass Grafting (CABG) at a tertiary care hospital with a new Open Heart
surgery program. Design: Retrospective study.
Setting: The Aga Khan University Hospital, Karachi.
Patients: Medical records of all patients undergoing CABG between November 1994 and July 1997
were reviewed and those in whom IABP device was used, were included in this study.
Results: A total of 15 patients had IABP suppOrt during the study period. Four surgeries were done
urgently while two were emergencies. There were three mortalities. Ejection fractions in all hut one
patient were impaired. Among the surviving patients, the average pre-IABP Cardiac Index was 2.6
litres/mm/meter2 which registered an average increase of 21.15% after the initiation of the IABP. The
Pulmonary Artery Wedge Pressure also showed an average reduction of 29.11% from the pre IABP
levels reflecting an increase in the cardiac output with the use of the IABP.
Conclusion: This series represents the early experience of a new cardiac surgery center in Pakistan in
the use of IABP. Although the numbers in this study are too small to derive any conclusions, the overall
morbidity and mortality in this short series are within acceptable limits in the high risk patients
included (JPMA 50:3, 2000).
Introduction 
Moulopoulos in 19621 first described the principle of Intra Aortic Balloon Pump (IABP). This
mechanical assist device works on the principle of diastolic counterpulsation, augmenting coronary
perfusion and reducing afterload. This improves myocardial oxygen supply, reduces oxygen demand
and enhances cardiac output. Kantrowitz in 1968 published the first report on the clinical performance
of the Balloon Pump2. Since that time, the Intra Aortic Balloon Pump has gradually become an
essential part of the cardiac surgeon’s armamentarium.
At the Aga Khan University Hospital (AKUH), Open Heart Surgery was started in November 1994.
This paper reviews the use and outcome of IABP inpatients undergoing CABG for coronary artery
disease, highlighting the indications, benefits and complications of the device.
Patients and Method 
Medical records of patitnts undergoing CABG for coronary artery disease at AKUH between
November 1994 and July 1997 were retrospectively reviewed. Isolated CABG cases in which IABP
was used were selected for the purpose of this study. Cases resulting from complications of Coronary
Angioplasty and those in which a cardiac procedure other than CABG was carried out simultaneously
were excluded. Both elective and emergency cases were included in this study.
Variables reviewed included age and gender of the patient, left ventricular ejection fraction, previous
history of myocardial infarction and the Canadian Cardiology Society class of the patient. Timing of
insertion and the total duration of dependence on the balloon pump, the concomitant use of inotropes,
the total length of stay and postoperative length of stay were also noted. Complications arising from the
use of IABP were analyzed along with mortality.
The balloon pump system used was the Datascope 97. The Balloon catheters used included Datacope
Cardiac Assist System R (Datascope Cardiac Assist Corp., Montvale, NJ, USA.) (9.5 and 10.5 French,
34cc) and Nicath TM Cardiac Assist, (Boston Scientific Corp., Watertown, MA, USA.) (9 French,
40cc). The size chosen depended upon the size and sex of the patient and the possibility of peripheral
vascular atherosclerotic disease, the smaller size being chosen for women and those with diminished
fern oral pulses. The method of insertion was by either percutaneous Seldinger technique or open cut
down method through the Common Femoral artery. The position was determined at operation by
approximating the tip of the catheter to the angle of Louis. The final position of the balloon was
confirmed on the postoperative chest X-ray in the ICU and adjustments made if necessary.
Results 
A total of 213 isolated CABG operations were performed at AKUH between November 1994 and July
1997. IABP support was used in 15 CABG cases during this period which have been included in this
study (Table 1).
The average age of the patients was 53 years, the range being from 37 years to 68 years including 10
men and 5 women.
All patients except one had some impairment of left ventricular function, ten of them having severe
dysfunction i.e., EF<30% (Table 2),
as determined by echocardiography or visual estimate from the left ventriculogram. Four operations
were done urgently and 2 were emergencies. The remaining were elective cases.
Fifteen patients had a previous history of myocardial infarction, five of them within 21 days prior to
admission. All patients were categorized according to the Canadian Cardiology Society criteria3. Two
patients were in Class II. 3 in class III, 5 in class IV-A, 3 in class IV-B while the remaining 2 were in
class IV-C (Table 3).
All patients receiving the IABP were monitored with Swan-Ganz catheters and some with left atrial
pressure lines as well. Among the surviving patients. the pre-IABP Cardiac Index (liters/rn in/meter2)
ranged from 1.86 to 3.2 1 (average 2.6). Post IABP Cardiac index ranged from 2.5 to 3.43 (average
3.15), an average increase of 21.15%. Pulmonary capillary wedge pressures pre-IABP ranged from 4 to
36 mm of Hg (average 15.87). Post-IABP, the pressures ranged from 3 to 2 I (average 11 .25), an
average reduction of 29.11%. An increase in cardiac index with reduction of PCWP (left ventricular
end-diastolic pressure) reflects an increase in cardiac output with reduction in oxygen demand, as is
expected from the IABP.
IABP support was utilized preoperatively in 3 cases. One was a 41 year old diabetic male with an
ejection fraction of 17% with high grade left main coronary artery stenosis and diffuse triple vessel
disease. This patient also had bilateral symptomatic carotid artery stenoses of more than 90%. He
underwent Carotid Endarterectomy on the left (dominant) side and a simultaneous CABG. The balloon
catheter was inserted pre-induction and support continued during the Carotid Endarterectomy and then
post-CABG for another 24 hours. The postoperative course was unremarkable.
The other patient was a 49 year old male with an ejection fraction of 20% who had congestive cardiac
failure (CCF) secondary to an ongoing myocardial infarction. He underwent CABG as an emergency
with the IABP inserted preoperatively to stabilize him. His operation was uneventful but he continued
to have congestive cardiac failure and resistant pleural effusion for the next six months. He eventually
had bilateral pleurodeses and subsequently did well.
The third case was of a 64 year old male with post infarction unstable angina and a second evolving
myocardial infarction complicated by CCF. He had an estimated ejection fraction of 49% on
echocardiography done prior to the second myocardial infarction. An intraaortic balloon was inserted
several hours preoperatively to relieve ischernia and stabilize his hernodynamic status and to maintain
circulation. His surgery was uneventful. He had persistent mild postoperative congestive cardiac
failure, which was managed medically with eventual relief Nine patients had the IABP inserted
intraoperatively while coming off cardiopulmonary bypass. They had low cardiac outputs and did not
respond thvorably to inotropic support or had ECG changes with apparently patent grafts.
Three patients required IA BP insertion postoperatively. One patient with an election fraction of 6 1%
had undergone a two vessel bypass on the beating heart without being put on cardiopulmonary bypass.
He sustained a myocardial infarction overnight and had to be re-explored for low cardiac output the
next morning. The distal ends of both grafts had thrombosed inspite ol patent anastamoses and were
replaced with new grafts on cardiopulmonary bypass. His postoperative course was unstable and was
on inotropes and IABP support for 4 days. He was successfully weaned off from both the
pharmacological as well as the mechanical support.
The second patient was 68 vears old and had unstable angina post mvocardial infarction with an
ejection fraction of 20%. He underwent CABG for severe triple vessel disease. lie had to he taken bacL
to the operating room the same day for bleeding and was re-explored. IABP was inserted for
intermittent pulmonary artery pressure elevations at lower perfusion pressures. H is recovery was
uneventful.
The third patient was a 37 year old male with an ejection fraction of 35% who had an urgent CABG for
post-infarction unstable angina and diffuse three vessel coronary artery disease. He required re-
exploration for excessive bleeding and sustained a myocardial infarction and went into biventricular
failure. lie had both a balloon catheter and a ventricular assist device placed but could not he weaned
off bypass and expired on the table. The average duration for which the balloon pump remained in use
was 1.8 (range of I to 4) days (Figure).
Fourteen patients required sim ultaneous inotropic support along with IABP to maintain hemodynarnic
stability. This was gradually reduced to a minimum or stopped prior to removal of the balloon in
surviving patients.
The total length of stay ranged from 6 to 38 (average 19.4) days in surviving patients. The post-
operative length of stay ranged from 6 days to 27 (average 11.2) days among the surviving patients.
There was one major morbidity as a result of IABP insertion. This was in a 50 years old obese, diabetic
lady who had an urgent CABG performed for unstable angina with diffuse 3 vessel coronary artery
disease following 10 days of intravenous antibiotic therapy for bacteraemia secondary to a urinary tract
infection. She underwent CABG but had difficulty being weaned off cardiopulmonary bypass and
needed IABP insertion. A size 9.5 Fr. Balloon catheter was inserted via the right common femoral
artery using the percutaneous Seldinger technique. She required mediastinal re-exploration for
postoperative ECG changes and an elevated CVP and was found to have thrombosed her right coronary
artery graft. An RCA graft thrombectomy was done since the anastomosis was patent. The IABP was
removed on the 3rd postoperative day. She developed severe vascular compromise in the affected limb
3 days postoperaively and was found to have occlusion of the right superficial femoral artery on
doppler for which she underwent a thrombectomy. A peripheral arterial bypass was not performed
because of the severe persistent infection she had developed in the thrombectomy wound. Her limb
ischaetnia recurred after 5 days. An angiogram done at that time showed subtotal occlusion of the
common femoral artery. An angioplasty was not considered for fear for disrupting the recent
arteriotomy. Her limb ischaemia persisted and she required toe amputations but ultimately had to have
a below knee amputation 7 months post CABG.
There were three mortalities in this series. One was a 56 year old male with a low ejection fraction
having sustained a myocardial infarction within the past 24 hours and had to undergo an emergency
CABG. He had profound LV dysfunction and required the insertion of IABP and a left ventricular assist
device to maintain circulation. These measures failed and the patient succumbed to circulatory failure.
The second was a 38 year old male who had undergone an urgent CABG for post myocardial infarction
unstable angina with an estimated ejection fraction of 35%. He had uneventful surgery but had to be re-
explored for excessive haemorrhage 6 hours later. He had prolonged hyoptension culminating in
myocardial infarction. Both the IABP and a left ventricular assist device were employed but were
unable to maintain his circulation.
The third lady was 65 years old with mild left ventricular dysfunction had an elective CABG for
unstable angina. She had a left internal mammary artery sequentially grafted to a diffusely diseased left
anterior descending artery which thrombosed, resulting in left ventricular damage and hypotension. The
chest was reopened immediately after closure and another Saphenous vein Y-graft was applied to the
LAD. She sustained myocardial damage and an IABP was inserted to maintain circulation. She was
shifted to the Intensive Care Unit with an open
chest but had a cardiac arrest later that night and could not be revived.
Discussion 
The use of aortic balloon counterpulsation has become a well established mechanism for assisting
circulation in patients undergoing Open Heart Surgery. The augmented aortic pressure during diastole
improves coronary circulation and the decreased aortic pressure during systole decreases the afterload
of the heart. It is of proven benefit in patients with hemodynamic instability following CABG4. The
benefits of instituting IABP support preoperatively inpatients with low ejection fraction undergoing
CABG has also been well demonstrated5.
At the Aga Khan University Hospital, 250 open heart operations have been performed since November
1994, of which 213 were isolated CABG’s. In the tertiary care setting of this hospital, it has not been
possible to exclude high risk cases, as is customary for centers initiating open heart surgery.
Mechanical assist devices for circulatory support like the lntra Aortic Balloon Pump and Ventricular
Assist Device are available and have been used when indicated. This study looks at the use of IABP
inpatients undergoing isolated CABG.
Some of the indications for which IABP is used in clinical practice include haemodynam ic
stabilization in patients with cardiogenic shock, insertion prior to Coronary Artery Bypass Grafting
(CABG) in patients with refractory myocardial ischaemia, in patients with acute ischaeniia secondary
to coronary angioplasty failure and in patients with cardiac failure or ischaemia following CABG6. In
this study all the patients having required IABP support had one or more of the above indications
present. The beneficial role of preoperative balloon catheterization in high risk patients with unstable to
refractory angina is proven. This maneuvre provides protection to the circulation till the time the
patient is put on cardiopulmonary bypass (CPB). Three patients in our series were in this category.
Nine patients required mechanical support to facilitate weaning them off CBP as they were unable to
maintain adequate blood pressure and cardiac output despite optimal pharmacological manipulation.
The remaining 3 patients needed IABP support postoperatively. All three needed mediastinal re-
exploration for various reasons and had the balloon catheters inserted during the second visit to the
operating room as they were unable to maintain stable circulation.
With the benefits of IABP becoming evident, another proposed indication of IABP is the preoperative
insertion in high risk patients with known coronary artery disease undergoing non-cardiac surgery7.
The choice of the method of insertion of the balloon catheter depended upon the timing of insertion, all
preoperative insertions being percutaneous and also on the presence of a palpable femoral artery
pulsation. Patients in whom a femoral pulse was palpable at the time of insertion had the catheter
inserted via the percutaneous route while those in whom a distinct pulse was not palpable had the
placement done by the open technique. Ninety-four percent of the patients in this series had an ejection
fraction of less than 50% and 87% patients were in the Canadian Cardiology Society Classification
category Ill or IV, indicating the extent and severity of ischaemic heart disease in the patients included.
Ever since Kantrowitz in 1 968? showed the clinical benefits of IABP, its wider usage has also brought
up the possible complications that can accompany its insertion. Kantrowitz et al2 classified
complications as being vascular, infectious and bleeding occurring in 22%, 22°/o and 7% patients
respectively in their series. Among women and diabetics, vascular complications occurred in 32%.
Naunheim et al8 reported a 12.4% complication rate and a mortality of 44% as is the case in most
reports. This essentially reflects the severity of the patient’s illness and not the effect of the IABP. The
complication rate in this series was 6%, one of the 15 sustaining ischaemia of the involved leg. Limb
ischaernia is a known complication of IABP insertion9 and may be the result of diffuse peripheral
vascular disease or a mismatch between the artery size and the catheter caliber. Female sex, diabetes
and unstable angina are independent risk factors for limb ischaemia in IABP patients2. All three risk
factors were present in our patient. Described methods of avoiding this complication include using the
smallest sized balloon catheter for the particular patient, insertion without the sheath or to insert the
balloon via the subclavian artery or into the aorta directly or through an attached vein graft Oconduit.
Other possible complications include arterial dissection, in situ rupture of the balloon and gas
embolism, thromboembolism and arterial perforation, major vessel blockage like the left subclavian
artery or the renal arteries. These are however.
rare complications. IABP is contraindicated when significant aortic regurgitation is present. The device
must therefore be used after careful consideration of the possible problems it can cause.
In three patients, all the pharmacological and mechanical support instituted was unable to maintain
hemodynamics. In two of these patients, the IABP was inserted intraoperatively while in the third
patient, the balloon catheter was inserted postoperatively to assist circulation. The overall mortality in
this series is 20%, which is less than to that noted in most other studies. This represents the total
mortality ol 1 .4% in our own series of 213 CABG patients.
The numbers in this present series are too small to derive any conclusive results but represent the early
experience of a new center in Pakistan using the IABP in patients undergoing coronary artery bypass
surgery. The overall morbidity and mortality rates in this short series are within acceptable limits in the
high risk patients included.
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